Medical/Pharmaceuticals
AVATAMED Partners CBmed in Europe on Precision Cancer Project
SINGAPORE, July 13, 2020 /PRNewswire/ -- AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, leveraging on a new technology in cancer research. The Medical Universities ofGraz and Vienna and the HEALTH Institute of Joanneum Researc...
2020-07-13 15:16
2856
SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 13, 2020 /PRNewswire/ -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the ...
2020-07-13 15:00
5074
Kering and Hubei Red Cross Foundation Supporting Biodiversity Conservation
* Focus on wildlife protection, public health and biodiversity preservation * Join force with local organizations to enhance public awareness, community participation and science educational initiatives SHANGHAI, July 13, 2020 /PRNewswire/ -- In January, Kering made a donation ofRMB 7.5 millio...
2020-07-13 14:52
3425
Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit
SHIJIAZHUANG, China, July 13, 2020 /PRNewswire/ -- In the evening of July 12, Yiling Pharmaceutical released the performance forecast for the first half year. In the first half of this year, the company achieved a net profit attributable to shareholders of 682 million to728 million Yuan (USD 97.4...
2020-07-13 12:25
12807
Translated Tool from NCCN Measures Mental Health "Temperature" of People with Cancer
PLYMOUTH MEETING, Pennsylvania, July 13, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)--an alliance of leading cancer centers in the United States--today announced the NCCN Distress Thermometer has been translated into46 languages. This free resource helps providers worl...
2020-07-13 08:05
2839
Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development
SHANGHAI and MELBOURNE, Australia, July 13, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced the appointment ofDirk Hoenemann, M.D as VP, Head of Medical Affairs for Asia Pacific Region (APAC) and Early Clinical Development. He will report directly to Mr.Thomas Karalis, Head...
2020-07-13 06:00
4629
World's First FDA IDE Coronary Patient Treated With a DEB
NYON, Switzerland, July 11, 2020 /PRNewswire/ -- MedAlliance has announced
enrollment of the first patient in its study ofSELUTION SLR™ 014 DEB
2020-07-11 08:00
3384
Ocumension Therapeutics Launches Initial Public Offering on Hong Kong Stock Exchange
SHANGHAI, July 10, 2020 /PRNewswire/ -- Ocumension Therapeutics ("Ocumension"), aChina-based ophthalmic pharmaceutical platform company, has today launched its Initial Public Offering (IPO) of the company's stock on The Stock Exchange of Hong Kong (HKEX). Ocumension plans to offer 105,930,000 shar...
2020-07-10 21:55
20085
CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial
TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug – CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02...
2020-07-10 20:43
4376
Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is an ef...
2020-07-10 13:32
1673
Merck Opens its Largest M Lab™ Collaboration Center in Shanghai
-- Focus on improving and optimizing drug discovery, development and manufacturing -- Integrated lab with customizable solutions, validation services, training and hands-on applications -- Shanghai center is newest and largest addition to Merck's global network of nine M Lab™ Collaboration Cente...
2020-07-10 13:00
3493
PolyU discovers the effect of chemical compound PTU on autophagy in zebrafish embryos, sheds light on cancer medication research
HONG KONG, July 10, 2020 /PRNewswire/ -- The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least one zeb...
2020-07-10 10:18
2802
Q Division Bringing Emerging Technology Expertise to Advanced Materials Pandemic Task Force
DAYTON, Ohio, July 9, 2020 /PRNewswire/ -- Q Division today announced their participation as commercial retail experts in the global Advanced Materials Pandemic Task Force (AMPT) - an international public-interest initiative focused on using Advanced Materials to solve some of humanity's most pre...
2020-07-09 22:00
1973
Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Effectiveness Against COVID-19 Virus
SINGAPORE, July 9, 2020 /PRNewswire/ -- Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease. Testing has demo...
2020-07-09 21:27
4140
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)AGC Biologics is partnering with clinical-stage biotech companyMolecular Partners AG to develop a new class of custom-built protein therapeutics known as DARPin®. AGC Biologics...
2020-07-09 13:00
2848
Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China
SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...
2020-07-09 08:00
12379
Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses
Paige leveraged the world's largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizesPaige with the...
2020-07-08 23:40
1782
Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis
STOCKHOLM, July 8, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to c...
2020-07-08 14:57
1806
Rapidly Changing Behaviours In 2020 Are Accelerating Consumer Embrace of Digital, Health, and Sustainability Trends, Says PwC
NEW YORK, July 8, 2020 /PRNewswire/ -- * 45% of global consumers say healthcare is one of the top three reasons for living in a city * 69% of global consumers are more focused on mental health and well being * 43% of global consumer expect businesses to be accountable for their environment...
2020-07-08 12:00
3389
Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China
SHANGHAI, July 8, 2020 /PRNewswire/ -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, and Zai Lab (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced an...
2020-07-08 11:37
2844
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5902
